Description

Shareholding pattern disclosure for Corona Remedies Limited post-IPO listing showing promoter holding of 68.9959% and public holding of 31.0041%.

Summary

BSE has disclosed the shareholding pattern for Corona Remedies Limited following the listing of its equity shares. The filing under Regulation 31(1)(a) shows the post-issue shareholding structure as of December 12, 2025, with total equity capital of 6,11,60,088 shares.

Key Points

  • Total equity shares: 6,11,60,088 fully paid-up shares
  • Promoter & Promoter Group: 6 shareholders holding 4,21,97,968 shares (68.9959%)
  • Public shareholders: 1,59,539 shareholders holding 1,89,62,120 shares (31.0041%)
  • Dematerialized shares: 5,68,20,841 shares (92.9051% of total)
  • Promoter shares in locked-in: 1,46,22,873 shares (77.1162% of promoter holding)
  • No partly paid-up shares, convertible securities, warrants, or outstanding ESOPs
  • No shares pledged or under non-disposal undertaking
  • No differential voting rights or depository receipts issued

Regulatory Changes

No regulatory changes announced. This is a standard shareholding pattern disclosure required under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Compliance Requirements

  • Listed entity has filed shareholding pattern under Regulation 31(1)(a)
  • Disclosure confirms compliance with minimum public shareholding requirements (31.0041% public holding)
  • Declaration provided for various securities categories (partly paid shares, convertible securities, warrants, ESOPs, DRs, locked-in shares, pledged shares)

Important Dates

  • December 12, 2025: Post-issue shareholding pattern date
  • December 12, 2025: Date of filing/disclosure

Impact Assessment

Market Impact: Medium - The listing adds a new equity to BSE with substantial public float of over 31%, meeting regulatory requirements. The high promoter holding of 68.9959% indicates strong promoter confidence.

Investor Impact: Significant portion of promoter shares (77.1162%) are locked-in, providing stability and commitment. High dematerialization rate of 92.9% facilitates easy trading. The presence of 1,59,539 public shareholders indicates broad-based participation.

Liquidity: With 1,89,62,120 shares available for public trading and no encumbrances on public holdings, the stock should have reasonable liquidity for investors.

Impact Justification

Routine post-IPO shareholding pattern disclosure for newly listed company. Important for investors tracking promoter holding and public float compliance.